News & events.

Our news.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

News

April 5, 2021

Published Peer-Reviewed Data Demonstrate Bamlanivimab’s High Potency Against SARS-CoV-2 and Support its Use as a Foundational Antibody Therapy to Treat and Prevent COVID-19

News

April 1, 2021

AbCellera and Gilead Sciences Announce New Multi-Year, Multi-Target Antibody Discovery Collaboration

Event

March 31, 2021

US East Coast Antibody Therapeutics Xchange

Event

March 31, 2021

Antibody Engineering & Therapeutics EU 2021

News

March 29, 2021

AbCellera Reports Full Year 2020 Business Results

Event

March 11, 2021

Biologics Europe: Online

Event

March 11, 2021

PEGS Boston Virtual 2021

News

March 10, 2021

AbCellera-Discovered Bamlanivimab Together with Etesevimab Reduced Hospitalizations and Prevented Death in Phase 3 Trial for Early COVID-19

News

March 5, 2021

EMA Advises Use of AbCellera-Discovered Bamlanivimab, Alone or Together with Etesevimab, to Treat Confirmed COVID-19 Patients

Event

February 23, 2021

Antibody Engineering & Therapeutics Asia Virtual Scientific Forum 2021